Final Round of Abstract Submission : June 24, 2018 | Welcome Message

Theme : Diagnostics and Treatment of Breast Cancer in Enriching the Wellness of Women

Organizing Committee Members



Science Access invites all the professors, delegates, researchers, experts to attend “World Congress on Breast Cancer and Women’s Health” during June 25-27, 2018 Rome, Italy. The Breast Cancer gatherings intend to investigate the crown examines in the tremendous field of science and united sciences. Science being the premise of life is a necessary part in each unique science from Life science to Rocket Science. These looks into when talked about can illuminate numerous youthful personalities in performing greater quality arranged research.
Breast Cancer Conference 2018 gives an immaculate stage to bring out such quality research works. These gatherings are stretched out by commenting key administrative ranges like Multi-disciplinary Breast Cancer, Biological of Breast Cancer. Giving a possibility, Science Access breast cancer Conferences have researchers, analysts, substance associations and all agents of pharmaceutical and science organization divisions can exhibit their apt discoveries and in the meantime get presented to a helpful cluster of research and most recent improvements. To talk about the issues and achievements in the field of Breast Cancer Science Access Conferences has taken the start to accumulate the world-class specialists both from scholastic and industry in a typical stage at its Breast Cancer meetings with the Theme: Diagnostics and Treatment of Breast Cancer in Enriching the Wellness of Women.
Breast cancer is one of the most common types of malicious cancers, which is prevalent in women above 40 years. As per World Health Organization (WHO) estimates, breast cancer accounted for around 521,000 deaths globally in 2012. Generally, hormone therapies are used for treating breast cancer, which next leads to resistance after continuous use of hormone therapy. This resistance towards hormone therapy is termed as hormone refractory breast cancer. Hence, there is an increasing need for the effective treatment in hormone refractory breast cancer market. The market holds tremendous future potential, as there is no standard therapy, approved for hormone refractory breast cancer. However, there are rising hopes to get approved therapies in near future as drugs such as trastuzumab and everolimus, alone or in combination, are under development for the effective treatment of hormone refractory breast cancers.
The key factors driving growth of this market includes, increasing global incidences of breast cancers, uprising prevalence rates of hormone refractory breast cancers, ageing population, demands of advanced therapeutics and increasing R&D investment on breast cancer drugs. The factors restraining the market growth are the social stigma related with breast cancer examinations, and insufficient advanced chemotherapeutic treatments. Substantial number of new chemical organization (NCEs) in different phases of clinical trials would emerge as a potential opportunity in the global hormone refractory breast cancer market.
The analysis, made in this report, helps in understanding the scheme adopted by various companies for gaining market share in hormone refractory breast cancer market. The report provides the quantitative analysis of the current market and estimations through 2014-2020 that assists in identifying the prevailing market opportunities to capitalize on.This report provides a comprehensive analysis of factors that drive and restrict the growth of the hormone obdurate breast cancer market.
Detailed study of the strategies of key leaders, partnerships, and acquisitions in the global hormone refractory breast cancer market would be informative for professionals in the corporate sector. Pin-point analysis of geographic segments helps to identify opportunities for growth within the hormone obdurate breast cancer market. Identification of key investment pockets for hormone refractory breast cancer market provides strategic assistance to decision makers.An analysis for the market attractiveness has been included for therapeutics, devices, and geographic regions along with a detailed analysis of factors responsible for the rapid growth of the market
Hormone refractory breast cancer market is fragment on the basis of mode of treatment and geography.
International Breast Cancer Research Foundation
McGrath Foundation


Target Audience

  • Presidents & CEO’s
  • Students
  • Surgeons
  • Nurses
  • Radiologists
  • Breast Cancer Biologist and oncologists

Contact Us

Feel Free To Contact Us

Address   : 2737 Live Oak Street, Huntington Park, CA 90255, USA
Phone No : +1 - 267-646-2200 , +1-302-428-9993
Fax           : +1 - 267-646-2200
Email Id    :



Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice, and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during the conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!